Cargando…
LIS1, a glyco-humanized swine polyclonal anti-lymphocyte globulin, as a novel induction treatment in solid organ transplantation
Anti-thymocyte or anti-lymphocyte globulins (ATGs/ALGs) are immunosuppressive drugs used in induction therapies to prevent acute rejection in solid organ transplantation. Because animal-derived, ATGs/ALGs contain highly immunogenic carbohydrate xenoantigens eliciting antibodies that are associated w...
Autores principales: | Rousse, Juliette, Royer, Pierre-Joseph, Evanno, Gwénaëlle, Lheriteau, Elsa, Ciron, Carine, Salama, Apolline, Shneiker, Françoise, Duchi, Roberto, Perota, Andrea, Galli, Cesare, Cozzi, Emmanuele, Blancho, Gilles, Duvaux, Odile, Brouard, Sophie, Soulillou, Jean-Paul, Bach, Jean-Marie, Vanhove, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978386/ https://www.ncbi.nlm.nih.gov/pubmed/36875084 http://dx.doi.org/10.3389/fimmu.2023.1137629 |
Ejemplares similares
-
XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants
por: Vanhove, Bernard, et al.
Publicado: (2021) -
Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants
por: Vanhove, Bernard, et al.
Publicado: (2023) -
Anti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs
por: Reynard, Olivier, et al.
Publicado: (2016) -
Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled Trial
por: Gaborit, Benjamin, et al.
Publicado: (2023) -
Pharmacokinetics and Safety of XAV-19, a Swine Glyco-humanized Polyclonal Anti-SARS-CoV-2 Antibody, for COVID-19-Related Moderate Pneumonia: a Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study
por: Gaborit, Benjamin, et al.
Publicado: (2021)